Navigation Links
Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results
Date:8/14/2008

5,274,200 5,301,847

Total other assets 71,880,852 55,430,716

Total assets $ 178,809,547 $ 161,552,074

TIENS BIOTECH GROUP (USA), INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS AS OF JUNE 30, 2008 AND DECEMBER 31, 2007 L I A B I L I T I E S A N D S H A R E H O L D E R S' E Q U I T Y

June 30, December 31,

2008 2007

As Adjusted

(Unaudited) (Note 1) CURRENT LIABILITIES:

Accounts payable $ 5,592,022 $ 4,070,906

Advances from customers - related

parties 2,493,135 1,700,838

Wages and benefits payable 892,276 1,250,685

Other taxes payable 451,829 536,819

Income taxes payable 2,803,788 665,726

Contractor deposits 738,208 595,128

Contactor payables 9,350,693 7,820,285

Other payables 1,137,420 1,133,539

Other payables - related parties 7,437,449 7,938,205

Dividend payable to minority interest -- 4,902,629

Current portion of long term debt,

related party 2,130,000 2,130,000

Total current liabilities 33,026,820 32,744,760

NON-CURRENT LIABILITIES

Long term debt, net of current

portion, related party 3,202,742 4,267,742

Other payables-non current
'/>"/>

SOURCE Tiens Biotech Group (USA), Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. eFuture Signs Contract to Provide Tiens Group with Retail Business Management System
2. Tiens Biotech Group (USA) Reports Fourth Quarter and Twelve-Month Results
3. Yongye Biotechnology International Announces Conference Call to Discuss Second Quarter 2008 Results
4. Oncolytics Biotech Inc. Completes Dose Escalation in Combination REOLYSIN(R)/Docetaxel Trial
5. Sinovac Biotech Ltd. Schedules 2007 Annual Meeting of Shareholders
6. ThirdBiotech Announces Kemeta as Newest Sponsor
7. Yongye Biotechnology International Retains CCG Investor Relations
8. InNexus Biotechnology Announces Launch of Large Scale Primate Study of DXL625
9. Mark C. Mirken Named New CEO and Chairman of the Board of Millennium Biotechnologies, Inc.
10. Ortho Biotech Announces Nationwide Voluntary Recall of Procrit(R) (Epoetin Alfa) Lot Number P114942A
11. New Book on the Business of Biotechnology

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)....23/PRNewswire-FirstCall/--PDLBioPharma,Inc.(PDL)(...edNovember27,2009astheex-dividenddateforits$200mil...ecuritizationtransactioncompletedonNovember2,2009....ldersofrecordontherecorddate,December1,2009.NASDAQ...1.67pershareofcommonstockforpurposesoftheex-divide...
(Date:11/23/2009)...c’s Sporicidin disinfectant solution and wip...fectants against H1N1 and Influenza A., , ...24, 2009 -- Contec Inc, the leading manufacturer o... Sporicidin disinfectants have been deemed by the... including Pandemic 2009 H1N1 influenza A virus (t...
(Date:11/23/2009)....23/PRNewswire/--Frost&Sullivan,theGrowthPartn...ratingleadershipandinnovationThursday,November19,2...uetheldinSanAntonio,Texas. ,, (Logo: http://www...TheHealthcareInnovationAwardsaregiventocompaniesth...managementofhealthcare.Suchcompanieshaveshownsucce...
(Date:11/20/2009)... , , , , , , , ... A team of scientists from Washington University...ing Harbor Laboratory and Iowa State University ha... , Click here for more information. ... , , , , , , , ...
Breaking Biology Technology:PDL BioPharma Announces Ex-Dividend Date of November 27 for Special Dividend 2Sporicidin Brand Disinfectant Kills H1N1 in 3 Minutes 2Excellence in Healthcare Innovation Recognized by Frost & Sullivan 2Excellence in Healthcare Innovation Recognized by Frost & Sullivan 3Amaizing: Corn genome decoded 2Amaizing: Corn genome decoded 3Amaizing: Corn genome decoded 4
...field of medical microbiology, biodefense and path...ray DNA analysis technologies , , LEXINGTON, Mass...ay announced the recruitment of Paul Keim, Ph.D., ...nior Investigator and Director of the Pathogen Gen...mics Research Institute) in Phoenix, Ariz., and Re...
... Institute (PI), the leading provider of specializ...iotech industry, today announced the release of a ...llence(TM) . The series was developed following a...training leaders from 17 large and midsize pharmac...at managed markets knowledge emerged as a top-thre...
...Vaccine Technologies Inc. (IVT), a vaccine develop...r research agreement with Defence Research and Dev... involves the preclinical application of IVT,s Dep...o explore new methods to prevent, prepare for, and...and his research team at DRDC are leaders in devel...
Other Biology Technology:Paul Keim Appointed to febit's Scientific Advisory Board 2Pharmaceutical Institute Launches New Training Series Focused on Managed Markets Excellence 2Pharmaceutical Institute Launches New Training Series Focused on Managed Markets Excellence 3ImmunoVaccine Technologies Collaborates with Defence Research & Development Canada to Strengthen Canada's Ability to Deal with Biological Threats 2
(Date:11/24/2009)...hat constitutes fish food is a matter of debate. A... fish get almost 50 percent of their carbon from t...tween the terrestrial and aquatic ecosystems. , ... shows this is not likely to be true. Algae provid...fe, according to research published this week in t...
(Date:11/23/2009)..., Cambridge, Mass. November 23, 2009 Applied mat...in lily ( Hosta lancifolia ), a characteristic lon...ly packed ripples along the edges. The simple caus...esulting from bending during differential growthwa...tretching foam ribbons. , Haiyi Liang, a postdoc...
(Date:11/23/2009)...CHAMPAIGN, Ill. A new study provides "incontrover...f Toba on the island of Sumatra about 73,000 years...miles from the epicenter, researchers report. , ...ers of ash into the atmosphere, leaving a crater (... kilometers long and 35 kilometers wide. Ash from ...
Breaking Biology News(10 mins):Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3The cause behind the characteristic shape of a long leaf revealed 2Supervolcano eruption -- in Sumatra -- deforested India 73,000 years ago 2Savient Pharmaceuticals Reports Second Quarter 2009 Financial Results 54024 1Savient Pharmaceuticals Reports Second Quarter 2009 Financial Results 54024 2Savient Pharmaceuticals Reports Second Quarter 2009 Financial Results 54024 3Savient Pharmaceuticals Reports Second Quarter 2009 Financial Results 54024 4Savient Pharmaceuticals Reports Second Quarter 2009 Financial Results 54024 5Savient Pharmaceuticals Reports Second Quarter 2009 Financial Results 54024 6Savient Pharmaceuticals Reports Second Quarter 2009 Financial Results 54024 7Savient Pharmaceuticals Reports Second Quarter 2009 Financial Results 54024 8Savient Pharmaceuticals Reports Second Quarter 2009 Financial Results 54024 9Savient Pharmaceuticals Reports Second Quarter 2009 Financial Results 54024 10Savient Pharmaceuticals Reports Second Quarter 2009 Financial Results 54024 11Savient Pharmaceuticals Reports Second Quarter 2009 Financial Results 54024 12Savient Pharmaceuticals Reports Second Quarter 2009 Financial Results 54024 13Savient Pharmaceuticals Reports Second Quarter 2009 Financial Results 54024 14Chindex International Announces Exclusive Distribution Agreements in China for Leading Clinical Chemistry and Aesthetic Laser Products 54021 1Chindex International Announces Exclusive Distribution Agreements in China for Leading Clinical Chemistry and Aesthetic Laser Products 54021 2Chindex International Announces Exclusive Distribution Agreements in China for Leading Clinical Chemistry and Aesthetic Laser Products 54021 3Chindex International Announces Exclusive Distribution Agreements in China for Leading Clinical Chemistry and Aesthetic Laser Products 54021 4Trusted LASIK Surgeons Welcomes Fort Lauderdale Vision Correction Surgery Expert Raymond P Gailitis M D F A C S 13464 1Trusted LASIK Surgeons Welcomes Fort Lauderdale Vision Correction Surgery Expert Raymond P Gailitis M D F A C S 13464 2Trusted LASIK Surgeons Welcomes Fort Lauderdale Vision Correction Surgery Expert Raymond P Gailitis M D F A C S 13464 3Trusted LASIK Surgeons Welcomes Fort Lauderdale Vision Correction Surgery Expert Raymond P Gailitis M D F A C S 13464 4Trusted LASIK Surgeons Welcomes Fort Lauderdale Vision Correction Surgery Expert Raymond P Gailitis M D F A C S 13464 5Trusted LASIK Surgeons Welcomes Fort Lauderdale Vision Correction Surgery Expert Raymond P Gailitis M D F A C S 13464 6Trusted LASIK Surgeons Welcomes Fort Lauderdale Vision Correction Surgery Expert Raymond P Gailitis M D F A C S 13464 7Trusted LASIK Surgeons Welcomes Fort Lauderdale Vision Correction Surgery Expert Raymond P Gailitis M D F A C S 13464 8
...s are highly valued by consumers yet their propert...hetic materials, placing a drain on our limited na...the National Physical Laboratory (NPL) are working...ll predict how we perceive naturalness. The result...they are interpreted by our senses as being fully ...
...aureate Chris Smit has concluded that small mammal...the development of natural diversity. Smit researc...land. It seems that prickly shrubs are important i...from grazing. Smit has also demonstrated that natu...ses are very important for the diversity of natura...
...th antibiotics is that, eventually, bacteria outsm...e gene that confers such resistance, a new drug ma...ersity scientists tested the new drug, called Ceft... multidrug-resistant Staphylococcus aureus (MRSA) ...rity of staphylococcal infections worldwide, both ...
Other Biology News:Scientists set out to measure how we perceive naturalness 2Scientists set out to measure how we perceive naturalness 3Tasty meal out of reach 2New antibiotic beats superbugs at their own game 2
... Conjugated peptides or recombinant proteins are u...uce antibodies in 2 rabbits. pre-immune and three...until the titer reaches 1:4,000 Western blot anal...rification Antibodies are eluted using both pH11 ...
Sheep Anti-Human IDO Monoclonal Antibody, Clone ZMD.420 from Invitrogen
ARCA (Anti Reverse Cap Analog) from Ambion
Rabbit anti-UBAP2L/NICE4 AbVantage Pack Polyclonal Antibody, Unconjugated from Bethyl Laboratories
Biology Products: